C, S., T, Y., & TYF, H. (2025). IL-33 and ILC2 in pancreatic cancer: Good, bad or a bit of both? Trends in cancer, 11(4), 274. https://doi.org/10.1016/j.trecan.2025.03.003
Chicago Style (17th ed.) CitationC, Simpson, Yip T, and Halim TYF. "IL-33 and ILC2 in Pancreatic Cancer: Good, Bad or a Bit of Both?" Trends in Cancer 11, no. 4 (2025): 274. https://doi.org/10.1016/j.trecan.2025.03.003.
MLA (9th ed.) CitationC, Simpson, et al. "IL-33 and ILC2 in Pancreatic Cancer: Good, Bad or a Bit of Both?" Trends in Cancer, vol. 11, no. 4, 2025, p. 274, https://doi.org/10.1016/j.trecan.2025.03.003.
Warning: These citations may not always be 100% accurate.